Long-term Sustainability of Response to Upadacitinib Among Patients with Active Rheumatoid Arthritis Refractory to Biological DiseaseModifying Anti-Rheumatic Drugs: Results Through 5 Years from SELECT-BEYOND
ARTHRITIS & RHEUMATOLOGY(2022)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要